Marlan D. Walker - 14 Mar 2022 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role: General Counsel
Signature: /s/ Marlan D. Walker
Issuer symbol: TXMD
Transactions as of: 14 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 15 Mar 2022, 07:00:15 UTC
Previous filing: 01 Oct 2021
Next filing: 28 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXMD	Common Stock	Options Exercise		+230,000	+796%		258,908	14 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXMD	Restricted Stock Units	Options Exercise	$0	-230,000	-100%	$0.000000^*	0	14 Mar 2022	Common Stock	230,000	$0.000000	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 14, 2022, the reporting person received 230,000 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on December 13, 2021.
F2	Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
F3	The RSUs vested on December 13, 2021.